Doerring, M.D., former FDA medical officer in the division of psychiatry and the founder and CEO of TaperClinic, he shares ...

Pershing is hopeful it’ll make an impact in reducing addiction but wants to see the new drug in use before casting a final judgment. “When oxycodone was released, Purdue Pharma told everyone this was ...

Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...

The FDA’s landmark approval of Journavx (suzetrigine)—the first non-opioid pain reliever in over two decades—represents a breakthrough in pain management. This breakthrough underscores the urgent need ...

The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the ...

Vertex Pharmaceuticals is marching beyond its cystic fibrosis stronghold with bold steps into pain management and genetic ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Chang Robotics, an autonomous technology and engineering leader, is excited to introduce Curabotics, a new company dedicated to improving healthcare through automation, robotics, and AI. Curabotics ...

FDA finds benzene contamination, Tronox to close a pigment plant, Sofinnova launches a European biotech fund, and more ...

MNP, one of Canada's largest national professional services firms, is pleased to announce that it will join forces with the chartered professional accounting firm, Houle and Associates Chartered ...